Distribuzione geografica
Continente #
NA - Nord America 2750
EU - Europa 1831
AS - Asia 967
OC - Oceania 80
AF - Africa 54
SA - Sud America 33
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5719
Nazione #
US - Stati Uniti d'America 2624
IT - Italia 880
CN - Cina 480
FR - Francia 192
DE - Germania 163
GB - Regno Unito 138
JP - Giappone 110
CA - Canada 96
AU - Australia 75
ES - Italia 57
CZ - Repubblica Ceca 55
IN - India 55
HK - Hong Kong 49
IR - Iran 49
NL - Olanda 42
IE - Irlanda 40
TW - Taiwan 35
RU - Federazione Russa 31
TR - Turchia 29
RO - Romania 26
SE - Svezia 26
VN - Vietnam 26
KR - Corea 25
ZA - Sudafrica 22
CH - Svizzera 21
MX - Messico 19
SG - Singapore 19
ID - Indonesia 18
PT - Portogallo 18
GR - Grecia 17
NO - Norvegia 17
TH - Thailandia 16
BE - Belgio 15
HU - Ungheria 12
HR - Croazia 11
DK - Danimarca 10
EG - Egitto 10
JO - Giordania 10
BR - Brasile 9
PK - Pakistan 9
CL - Cile 8
KE - Kenya 8
LT - Lituania 8
TT - Trinidad e Tobago 8
UA - Ucraina 8
AR - Argentina 7
AT - Austria 7
MA - Marocco 7
BA - Bosnia-Erzegovina 6
CO - Colombia 6
FI - Finlandia 6
IQ - Iraq 6
PL - Polonia 6
MY - Malesia 5
NZ - Nuova Zelanda 5
PH - Filippine 5
BG - Bulgaria 4
IL - Israele 4
QA - Qatar 4
RS - Serbia 4
BY - Bielorussia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AP - ???statistics.table.value.countryCode.AP??? 2
CY - Cipro 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
LU - Lussemburgo 2
ME - Montenegro 2
MO - Macao, regione amministrativa speciale della Cina 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
BH - Bahrain 1
CM - Camerun 1
EC - Ecuador 1
IS - Islanda 1
KW - Kuwait 1
LY - Libia 1
MK - Macedonia 1
NG - Nigeria 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TG - Togo 1
UY - Uruguay 1
Totale 5719
Città #
Milan 345
Fairfield 297
Houston 193
Ashburn 137
Woodbridge 137
Buffalo 126
Seattle 117
Ann Arbor 109
Cambridge 109
Santa Cruz 106
Wilmington 94
Beijing 79
Shanghai 59
Nanjing 50
Southend 39
Dublin 38
Rome 38
Boardman 34
Munich 34
San Diego 32
Tokyo 29
Las Vegas 25
Guangzhou 24
Los Angeles 24
Wuhan 23
Hangzhou 21
London 21
Central District 19
Chicago 18
Clearwater 18
Ottawa 18
Taipei 18
Changsha 17
Central 16
Redmond 16
Toronto 16
Fleming Island 15
Heidelberg 15
Jinan 14
New York 14
Singapore 14
Changchun 13
Madrid 13
Milpitas 13
Amsterdam 12
Phoenix 12
Tehran 12
Bologna 11
Henderson 11
Barcelona 10
Chengdu 10
Muizenberg 10
Naples 10
Provo 10
San Francisco 10
Tianjin 10
Turin 10
Bengaluru 9
Dong Ket 9
Falls Church 9
Istanbul 9
Mountain View 9
Bangkok 8
Duncan 8
North Wales 8
Port of Spain 8
Argenta 7
Basel 7
Boston 7
Brussels 7
Chestermere 7
Columbus 7
Florence 7
Hefei 7
Ho Chi Minh City 7
Kaunas 7
Philadelphia 7
Riva 7
San Jose 7
Shenyang 7
Zagreb 7
Acapulco de Juárez 6
Atlanta 6
Berlin 6
Bucharest 6
Melbourne 6
Monza 6
New Orleans 6
Norwalk 6
Osaka 6
Palermo 6
Sarajevo 6
Scranton 6
Stockholm 6
Athens 5
Bari 5
Bergamo 5
Birmingham 5
Bitonto 5
Canberra 5
Totale 3035
Nome #
Entinostat for the treatment of breast cancer, file dfa8b99f-34e8-748b-e053-3a05fe0a3a96 687
Immunotherapy in breast cancer patients: A focus on the use of the currently available biomarkers in oncology, file dfa8b9a7-3b58-748b-e053-3a05fe0a3a96 597
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines, file dfa8b99b-c6c1-748b-e053-3a05fe0a3a96 567
Managing side effects of immune checkpoint inhibitors in breast cancer, file dfa8b9a7-30c4-748b-e053-3a05fe0a3a96 370
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies, file dfa8b9a6-3470-748b-e053-3a05fe0a3a96 296
Global cancer control: responding to the growing burden, rising costs and inequalities in access, file dfa8b99a-94db-748b-e053-3a05fe0a3a96 273
A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer, file dfa8b99d-1c42-748b-e053-3a05fe0a3a96 269
RNAi screens identify CHD4 as an essential gene in breast cancer growth, file dfa8b996-deda-748b-e053-3a05fe0a3a96 254
Expression of tumor-associated antigens in breast cancer subtypes, file dfa8b9a0-784e-748b-e053-3a05fe0a3a96 195
Barriers to the use of trastuzumab for HER2+ breast cancer and the potential impact of biosimilars : a physician survey in the united states and emerging markets, file dfa8b99a-c2e6-748b-e053-3a05fe0a3a96 180
Highlights from the 14th St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer, file dfa8b99b-fff7-748b-e053-3a05fe0a3a96 139
Pten alterations and their role in cancer management: Are we making headway on precision medicine?, file dfa8b9a2-b15e-748b-e053-3a05fe0a3a96 131
Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients : a Single-Institute Study, file dfa8b99a-a57b-748b-e053-3a05fe0a3a96 124
WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells, file dfa8b9a2-ebc7-748b-e053-3a05fe0a3a96 123
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review, file dfa8b9a7-0a7a-748b-e053-3a05fe0a3a96 121
Impact of autoimmune diseases on outcome of patients with early breast cancer, file dfa8b99a-707b-748b-e053-3a05fe0a3a96 112
Immune checkpoint blockade in cancer treatment : a double-edged sword cross-targeting the host as an "innocent bystander", file dfa8b99a-d059-748b-e053-3a05fe0a3a96 110
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date., file dfa8b99a-822e-748b-e053-3a05fe0a3a96 106
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer, file dfa8b9a7-3f2e-748b-e053-3a05fe0a3a96 105
Immune approaches to the treatment of breast cancer, around the corner?, file dfa8b99b-1511-748b-e053-3a05fe0a3a96 98
Biopsy confirmation of metastatic sites in breast cancer patients : clinical impact and future perspectives, file dfa8b99b-1508-748b-e053-3a05fe0a3a96 95
Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs, file dfa8b99f-7c4c-748b-e053-3a05fe0a3a96 95
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials, file dfa8b9a5-dfe5-748b-e053-3a05fe0a3a96 87
Antibody–drug conjugates in solid tumors: a look into novel targets, file dfa8b9a6-4a77-748b-e053-3a05fe0a3a96 84
Impact of Rehabilitation on Breast Cancer Related Fatigue : A Pilot Study, file dfa8b9a5-1f3a-748b-e053-3a05fe0a3a96 77
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials, file dfa8b9a2-a6d8-748b-e053-3a05fe0a3a96 76
HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence, file dfa8b99f-01e5-748b-e053-3a05fe0a3a96 71
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer, file dfa8b9a5-d6a9-748b-e053-3a05fe0a3a96 66
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management, file dfa8b9a7-b359-748b-e053-3a05fe0a3a96 65
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00, file dfa8b9a6-d5de-748b-e053-3a05fe0a3a96 62
Tumour dormancy and clinical implications in breast cancer, file dfa8b99b-2238-748b-e053-3a05fe0a3a96 51
Highlights from the 13th St Gallen International Breast Cancer Conference 2013 : access to innovation for patients with breast cancer: How to speed it up?, file dfa8b99b-6724-748b-e053-3a05fe0a3a96 45
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer, file dfa8b9aa-53ce-748b-e053-3a05fe0a3a96 16
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials, file dfa8b9aa-2ac0-748b-e053-3a05fe0a3a96 13
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors : a Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group : Part 1 : Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research, file dfa8b999-480e-748b-e053-3a05fe0a3a96 8
Cardiotoxicity of anticancer treatments : epidemiology, detection, and management, file dfa8b99b-1337-748b-e053-3a05fe0a3a96 8
Safety of covid-19 mrna vaccines in patients with cancer enrolled in early-phase clinical trials, file dfa8b9a9-e0ee-748b-e053-3a05fe0a3a96 8
Liquid biopsies for solid tumors : understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies, file dfa8b99a-cddb-748b-e053-3a05fe0a3a96 7
Molecular pathways : human leukocyte antigen G(HLA-G), file dfa8b99a-dddc-748b-e053-3a05fe0a3a96 7
Strategies to modulate the immune system in breast cancer : checkpoint inhibitors and beyond, file dfa8b99b-0fab-748b-e053-3a05fe0a3a96 7
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer, file dfa8b99b-7766-748b-e053-3a05fe0a3a96 7
Best management of locally advanced inoperable breast cancer, file dfa8b99b-215a-748b-e053-3a05fe0a3a96 6
Mechanism of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist, file dfa8b994-eef9-748b-e053-3a05fe0a3a96 5
Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer, file dfa8b99a-de08-748b-e053-3a05fe0a3a96 5
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer, file dfa8b99b-1740-748b-e053-3a05fe0a3a96 5
No link between breast cancer and meningioma : results from a large monoinstitutional retrospective analysis, file dfa8b99b-1b16-748b-e053-3a05fe0a3a96 5
Developing an effective breast cancer vaccine : challenges to achieving sterile immunity versus resetting equilibrium, file dfa8b99b-2543-748b-e053-3a05fe0a3a96 5
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy, file dfa8b9a0-a937-748b-e053-3a05fe0a3a96 5
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials, file dfa8b9a8-17a4-748b-e053-3a05fe0a3a96 5
Crosstalk between bone niche and immune system : osteoimmunology signaling as a potential target for cancer treatment, file dfa8b99a-7f5e-748b-e053-3a05fe0a3a96 4
QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation : a comprehensive review, file dfa8b99a-926b-748b-e053-3a05fe0a3a96 4
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : results from Neo-ALTTO, file dfa8b99a-9dd9-748b-e053-3a05fe0a3a96 4
Neoadjuvant model for testing emerging targeted therapies in breast cancer, file dfa8b99a-a606-748b-e053-3a05fe0a3a96 4
Monitoring tumor-derived cell-free DNA in patients with solid tumors : clinical perspectives and research opportunities, file dfa8b99b-2527-748b-e053-3a05fe0a3a96 4
Locoregional recurrence in patients with HER2 positive breast cancer, file dfa8b990-c251-748b-e053-3a05fe0a3a96 3
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer, file dfa8b990-f444-748b-e053-3a05fe0a3a96 3
Adjuvant trastuzumab in elderly with HER-2 positive breast cancer : a systematic review of randomized controlled trials, file dfa8b99a-5678-748b-e053-3a05fe0a3a96 3
The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations, file dfa8b99a-c3dd-748b-e053-3a05fe0a3a96 3
Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer, file dfa8b99b-1d68-748b-e053-3a05fe0a3a96 3
Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial, file dfa8b99d-1cb1-748b-e053-3a05fe0a3a96 3
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer, file dfa8b9a3-0274-748b-e053-3a05fe0a3a96 3
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus, file dfa8b9a5-e433-748b-e053-3a05fe0a3a96 3
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00, file dfa8b995-4307-748b-e053-3a05fe0a3a96 2
Breast conservation following neoadjuvant therapy for breast cancer in the modern era : are we losing the opportunity?, file dfa8b99a-d857-748b-e053-3a05fe0a3a96 2
Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer, file dfa8b9a5-b46b-748b-e053-3a05fe0a3a96 2
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis, file dfa8b9a6-2d2d-748b-e053-3a05fe0a3a96 2
Adjuvant treatment of early male breast cancer, file dfa8b9a6-70cc-748b-e053-3a05fe0a3a96 2
Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis, file dfa8b9a6-8924-748b-e053-3a05fe0a3a96 2
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors, file 1a546335-d67d-46c8-8910-27494840e7a8 1
Metaplastic breast cancer: an all-round multidisciplinary consensus, file 2ba1d62d-e7b3-4340-9da2-7c7ea96303b5 1
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: a randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine, file dfa8b992-3a36-748b-e053-3a05fe0a3a96 1
Over-using chemotherapy in the adjuvant setting, file dfa8b996-cfb6-748b-e053-3a05fe0a3a96 1
Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?, file dfa8b99a-be4e-748b-e053-3a05fe0a3a96 1
Erratum: Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556, file dfa8b99b-e9a1-748b-e053-3a05fe0a3a96 1
Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis, file dfa8b99d-1c9f-748b-e053-3a05fe0a3a96 1
Peptide vaccines in early breast cancer, file dfa8b99d-ba30-748b-e053-3a05fe0a3a96 1
Targeting the subtypes of breast cancer: Rethinking investigational drugs, file dfa8b99e-ae12-748b-e053-3a05fe0a3a96 1
Treatment in real-life patients with HER2-positive metastatic breast cancer: What we learn from the KAMILLA trial?, file dfa8b99f-7011-748b-e053-3a05fe0a3a96 1
Pharmacological management of male breast cancer, file dfa8b9a3-1f9d-748b-e053-3a05fe0a3a96 1
Tumour infiltrating lymphocytes and correlation with response to intensified platinum-based chemotherapy in BRCA-like tumours, file dfa8b9a5-c8c2-748b-e053-3a05fe0a3a96 1
Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents, file dfa8b9a6-61be-748b-e053-3a05fe0a3a96 1
Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials, file dfa8b9a6-68b5-748b-e053-3a05fe0a3a96 1
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review, file dfa8b9a6-ee6c-748b-e053-3a05fe0a3a96 1
Managing side effects of immune checkpoint inhibitors in breast cancer, file dfa8b9a7-2b18-748b-e053-3a05fe0a3a96 1
Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer, file dfa8b9a8-60e9-748b-e053-3a05fe0a3a96 1
Evolution of low HER2 expression between early and advanced-stage breast cancer, file dfa8b9a9-77e9-748b-e053-3a05fe0a3a96 1
Targeting brain metastases in breast cancer, file dfa8b9a9-c44a-748b-e053-3a05fe0a3a96 1
Totale 5928
Categoria #
all - tutte 8550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8550

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201813 0000 00 00 00013
2018/2019489 8152723 3019 2543 49579895
2019/2020840 564465102 8068 7083 93685556
2020/20211022 66796458 9665 7173 8397118152
2021/20221927 147150123180 219116 144123 175123272155
2022/20231423 83118273206 13194 126103 819710011
Totale 5928